Radiology - Technology Information Portal
Saturday, 4 May 2024
• Welcome to Radiology-TIP.com!
     • Sign in / Create account
 
 'Ionic Monomer' p3
SEARCH   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Searchterm 'Ionic Monomer' found in 2 terms [
] and 15 definitions [
]
Result Pages :
Isovue®
Isovue® is a nonionic contrast agent with a wide range of iodine concentrations.
Isovue-370 with its highest concentration of contrast approved for CT is an excellent agent to match the speed and power of multi-detector row CT (MDCT). Prefilled syringes provide easy and efficient contrast media handling. Isovue-M® is indicated for CT myelography.

See also Contrast Media Injector, Single-Head CT Power Injector, Multi-Head Contrast Media Injector, Syringeless CT Power Injector.
Drug Information and Specification
NAME OF COMPOUND
Iopamidol
DEVELOPER
Bracco Diagnostics, Inc.
INDICATION
Brain and body computed tomography, urography, angiography, phlebography (peripheral venography)
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
413, 524, 616 and 796 mosm/kgH2O
IODINE CONCENTRATION
200, 250, 300 and 370 mg/mL
Depending on the concentration: 100 - 200 mL, do not exceed 60 grams of iodine.
PREPARATION
Ready-to-use product
STORAGE
Store at 20-25° Celsius (68-77° Fahrenheit). Protect from light.
PRESENTATION
Depending on the concentration: 20, 30 and 50 vials; 75, 100, 125, 150, 175 and 200 mL bottles
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Low-Osmolar Contrast Media
(LOCM) Low-osmolar contrast media have a wide range of indications due to their lower side effects. The type of contrast media is an important risk factor for an adverse reaction.
LOCM have not completely replaced contrast media with higher osmolality due to their higher cost. Guidelines of professional organizations give recommendations for the selective use of low-osmolar contrast media for certain high-risk patients.
There are ionic and nonionic iodinated contrast materials with low osmolality available:
nonionic dimer.
An adverse reaction occurs in low-risk patients who receive conventional ionic contrast agents more often than in high-risk patients who receive nonionic LOCM.

See also Contrast Enhancement, Biliary Contrast Agents, Safety of Contrast Agents and Contrast-Induced Nephropathy.
Nonionic Contrast Agents
Nonionic contrast agents are a group of contrast media that do not dissociate into charged particles. Many of the side effects of contrast agents are due to the injection of a solution with high osmolality compared to blood. Nonionic contrast agents have a low osmolality and tend to have less toxicity. However, as with all iodinated contrast agents, serious or fatal reactions have been associated with their use.
Due to their lower neurotoxicity, nonionic contrast agents can also be used for myelography. The only FDA approved agent, iodixanol, is iso-osmolar to blood, which makes it preferable for examinations of the central nervous system and cardiovascular studies. Because of its higher costs relative to other nonionic agents, the use is sometimes reserved for patients with high risk of nephrotoxicity.

See also Nonionic Dimer, Nonionic Monomer and CM Ratio.
Nonionic Dimer
A nonionic dimer consists of 2 joined nonionic monomers. Nonionic dimers are used as x-ray and CT contrast media.
Nonionic dimers have the lowest osmolarity. These contrast materials contain 6 iodine atoms for every 1 particle in solution (CM ratio=6). Modern CT techniques require fast bolus injections and thus low-viscosity, high-concentration, well-tolerated contrast agents. Nonionic dimers have the highest viscosity, which limits the clinical usefulness. Examples of nonionic dimers are iotrolan (Isovist®) and iodixanol (Visipaque).

See also Contrast Agents.
Omnipaque
Omnipaque is a low-osmolar, nonionic, contrast medium with a broad range of indications, for example intravascular diagnostic procedures such as coronary angiography, spinal cord imaging, and body cavity procedures including shoulder and knee joints. Omnipaque is approved for use in adults and children, and is available in a wide variety of packagings.

See also Nonionic Contrast Agents.

Drug Information and Specification
NAME OF COMPOUND
Iohexol
DEVELOPER
INDICATION
Brain and body computed tomography, urography, angiography
APPLICATION
Intravascular
PHARMACOKINETIC
Renal excretion
CHEMICAL BOND
520, 672, 844 mosm/kgH2O
IODINE CONCENTRATION
240, 300 or 350 mg iodine
50 to 250 mL depending on concentration and examination
PREPARATION
Ready-to-use product
STORAGE
Store below 30°Celsius (86°Fahrenheit)
PRESENTATION
50, 75, 100, 125, 150, 200 or 250mL bottle or +PLUSPAK (polymer bottle)
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Result Pages :
 
Share This Page
Facebook
Twitter
LinkedIn
Look
      Ups
Radiology - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • Medical-Ultrasound-Imaging
Copyright © 2008 - 2024 SoftWays. All rights reserved.
Terms of Use | Privacy Policy | Advertising
 [last update: 2023-11-06 02:01:00]